Literature DB >> 1831844

Inflammatory mediators and the destruction of bone.

G R Mundy1.   

Abstract

Bone is remodelled by the coordinated actions of osteoclasts and osteoblasts. Cellular remodelling occurs in discrete packets of bone, and is regulated by local cytokines produced in the environment of the remodelling cells. These cytokines are secreted by immune cells and by bone cells. In addition, some growth regulatory factors are incorporated into the noncollagenous bone matrix and are released in an active form when bone is stimulated to resorb. Complex interactions between these cytokines and their target cells are responsible for the normal delicate balance between bone resorption and bone formation, and disorders of bone loss are due to imbalances between the rates of resorption and formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831844     DOI: 10.1111/j.1600-0765.1991.tb01647.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  14 in total

1.  Comparison between inflammation-related markers in peri-implant crevicular fluid and clinical parameters during osseointegration in edentulous jaws.

Authors:  Amália M Bielemann; Raissa M Marcello-Machado; Fábio Renato Manzolli Leite; Frederico Canato Martinho; Otacílio Luiz Chagas-Júnior; Altair Antoninha Del Bel Cury; Fernanda Faot
Journal:  Clin Oral Investig       Date:  2017-07-14       Impact factor: 3.573

2.  Differential induction of inflammatory cytokines and reactive oxygen species in murine peritoneal macrophages and resident fresh bone marrow cells by acute staphylococcus aureus infection: contribution of toll-like receptor 2 (TLR2).

Authors:  Ajeya Nandi; Somrita Dey; Julie Biswas; Pooja Jaiswal; Shamreen Naaz; Tamima Yasmin; Biswadev Bishayi
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

3.  Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis.

Authors:  L Shapira; C Champagne; T E Van Dyke; S Amar
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10.

Authors:  Y Houri-Haddad; W A Soskolne; A Halabi; V Barak; L Shapira
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

5.  Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.

Authors:  H Yu; Q Li; B Herbert; R Zinna; K Martin; C R Junior; K L Kirkwood
Journal:  Gene Ther       Date:  2010-11-11       Impact factor: 5.250

6.  Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola.

Authors:  G Rosen; M N Sela; R Naor; A Halabi; V Barak; L Shapira
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  The influence of bone formation on anchoring percutaneous devices with titanium fibre mesh flanges.

Authors:  M M Shalabi; X F Walboomers; J A Jansen
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

Review 8.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

9.  Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones.

Authors:  I Holt; M W Davie; I P Braidman; M J Marshall
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

10.  Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.

Authors:  Devki Sukhtankar; Alec Okun; Anupama Chandramouli; Mark A Nelson; Todd W Vanderah; Anne E Cress; Frank Porreca; Tamara King
Journal:  Mol Pain       Date:  2011-10-20       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.